Small Cap
With a marketcap of ₹ 19,573.05 Cr Stock is ranked 332
Small Cap
With a marketcap of ₹ 19,573.05 Cr Stock is ranked 332
Emcure Pharma Investment Return
Short Term
Long Term
Emcure Pharma Return Calculator
Emcure Pharma Revenue and Profit and Growth
Strength
- The company's Book Value Per Share (BVPS) is improving consistently for last 2 years
- The company is showing good quarterly growth with YoY Net Profit Growth of 30.93%, the YoY Revenue Growth of 21.49% and the NetProfit for the last quarter of Rs. 127.37 Cr.
- The stock price of the company is lurking near its 52 week low
Weakness
- RSI of the company is 33.91
Emcure Pharma Screener FAQs
What types of data can I screen with a Emcure Pharma screener?
The Emcure Pharma screener can be used to check different types of data, such as market capitalization, stock P/E, PB ratio, current price, book value, ROE, 52W high/low, dividend yield, and face value. It also shows short-term and long-term data of the Emcure Pharma.
What is the importance of using a stock screener for analyzing Emcure Pharma?
You can use the Emcure Pharma stock screener to analyze stocks based on specific criteria, helping you choose stocks for investments based on real-time data.
Is the Emcure Pharma Stock Screener suitable for both short-term and long-term investors?
Yes, you can use the Emcure Pharma Stock Screener for both short-term and long-term. Using the short term, you can check data for periods ranging from 1 week to 6 months. On the other hand, if you are looking to invest long-term, you can check data for periods ranging from 1 year to 10 years.
